The addition of an alpha-borano or alpha-H group to PMEA and PMPA impairs their phosphorylation by human AMP kinases 1 and 2, likely due to disruption of critical arginine interactions.
Answers are grounded in this paper and cite their sources.
These modifications may hinder PMEA/PMPA activation in humans; leaves open optimal designs for kinase-dependent nucleotide analogs.
Adenylate kinases are involved in the activation of antiviral drugs such as the acyclic phosphonates analogs PMEA and (R)PMPA. We examine the in vitro phosphorylation of PMEA and PMPA bearing a borano- or a H- group on the phosphorus atom. The alpha-borano or alpha-H on PMEA and PMPA were detrimental to the activity of recombinant human AMP kinases 1 and 2. Docking PMEA to the active site of AMP kinase 1 indicated that the borano group may prevent two conserved critical Arg interactions with the alpha-phosphate, resulting in substrate bad positioning.
No takes yet. Share an insight, caveat, or question.
Topalis et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: